Enlivex Ltd (ENLV)

• Market cap: $148M
• 1 day: -0.49%
• 5 days: -15.75%
• 1 month: -11.8%
• 3 months: -43.58%
• 6 months: -26.05%
• Year to date: -18.53%
• 1 year: -41.43%
• 5 years: -93.43%
• 10 years: -99.16%
• Sector: Healthcare
• Industry: Biotechnology

About: Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Employees: 34